Cost-effectiveness analysis of antiemetics therapy in breast cancer patients with moderate emetogenic chemotherapy in Prof. Dr. Margono Soekarjo Hospital, Indonesia
Chemotherapy-induced nausea and vomiting (CINV) significantly reduce the life quality of cancer patients. A 5-HT3 receptor antagonist, corticosteroid, and H2-blocker have been used to control moderate nausea and vomit in cancer patients. The exploration of the cost-effectiveness of several antiemeti...
Enregistré dans:
Auteurs principaux: | Ida Dzikriyani, Didik Setiawan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Universitas Ahmad Dahlan
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f48b8a3eb23a45f08f387cecb2e0b55b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Eficacia de la dexametasona en el tratamiento agudo de náuseas y vómitos posoperatorios: Comparación con droperidol y ondansetrón
par: Muñoz,Hernán R, et autres
Publié: (2006) -
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT
par: Stephen Robson, et autres
Publié: (2021) -
Comparison of the Prophylactic Effect of Ondansetron and Dexamethasone on Postoperative Nausea and Vomiting after Intrathecal Meperidine in Women Scheduled for Elective Cesarean Section
par: N Banihashem, et autres
Publié: (2011) -
COMPARATIVE AND MORPHOLOGIC EVALUATION OF EFFECTS OF ASPIRIN AND RANITIDINE ON WOUND REPAIR OF GASTRIC MUCOSA
par: Giovanoni,Marisa, et autres
Publié: (1998) -
Evaluation of pre-chemotherapy antiemetic prescriptions in a hospital unit
par: Andressa B. Souza, et autres
Publié: (2020)